BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 24028620)

  • 1. Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.
    Cheng ZY; Tian X; Gao J; Li HM; Jia LJ; Qiao HL
    PLoS One; 2014; 9(1):e87234. PubMed ID: 24498050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of the interaction between luteolin and magnoflorine in rats.
    Liu L; Li X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14356. PubMed ID: 37731180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine.
    Zhang RX; Dong K; Wang Z; Miao R; Lu W; Wu XY
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.
    Hu Z; Guan Y; Hu W; Xu Z; Ishfaq M
    Iran J Basic Med Sci; 2022 Jan; 25(1):14-26. PubMed ID: 35656442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of B-Ring Unsubstituted Flavones.
    Ancuceanu R; Dinu M; Dinu-Pirvu C; AnuĊ£a V; Negulescu V
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31374885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single Dose of Baicalin Has No Clinically Significant Effect on the Pharmacokinetics of Cyclosporine A in Healthy Chinese Volunteers.
    Liu R; Li X; Wei J; Liu S; Chang Y; Zhang J; Zhang J; Zhang X; Fuhr U; Taubert M; Tian X
    Front Pharmacol; 2019; 10():518. PubMed ID: 31156436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences.
    Komura H; Iwaki M
    Drug Metab Rev; 2011 Nov; 43(4):476-98. PubMed ID: 21859377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics.
    Noh K; Kang Y; Nepal MR; Jeong KS; Oh DG; Kang MJ; Lee S; Kang W; Jeong HG; Jeong TC
    Molecules; 2016 Mar; 21(3):337. PubMed ID: 26978333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the absorption mechanisms of baicalin and baicalein in rats.
    Taiming L; Xuehua J
    J Pharm Sci; 2006 Jun; 95(6):1326-33. PubMed ID: 16628739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
    Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
    J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced system exposures of total rhein and baicalin after combinatory oral administration of rhein, baicalin and berberine to beagle dogs and rats.
    Wang Z; Hu H; Chen F; Lan K; Wang A
    J Ethnopharmacol; 2013 Jan; 145(2):442-9. PubMed ID: 23159470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intestinal first-pass metabolism of baicalein in its absorption process.
    Zhang L; Lin G; Chang Q; Zuo Z
    Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
    Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
    Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids.
    Morisaki T; Hou XL; Takahashi K; Takahashi K
    J Pharm Pharmacol; 2013 Oct; 65(10):1526-35. PubMed ID: 24028620
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.